Jump to content

Page values for "Dapagliflozin"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringDapagliflozin
brandStringFarxiga (US), Forxiga (international)
structureFile
classesList of String, delimiter: ,[[:Category:SGLT2_inhibitors|SGLT2 inhibitor]] [[:Category:Antihyperglycemic_agents|Antihyperglycemic agent]] [[:Category:Heart_failure_medications|Heart failure medication]]
mechanismString
usesString'"`UNIQ--vote-0000054E-QINU`"', '"`UNIQ--vote-0000054F-QINU`"', '"`UNIQ--vote-00000550-QINU`"', '"`UNIQ--vote-00000551-QINU`"'
starting_doseString10 mg PO once daily in the morning; 5 mg starting in heart failure
preparationsString5 mg, 10 mg tablets
fda_maxString10 mg/d
pill_idText
routesList of String, delimiter: ,Oral
onsetStringGlycosuria within hours; HbA1c effect at 12 weeks; CV/renal benefits over months
durationString24 hours
halflifeString~12.9 hours'"`UNIQ--ref-00000552-QINU`"'
bioavailabilityString~78% (oral; high-fat meal modestly reduces but is not clinically significant)'"`UNIQ--ref-00000553-QINU`"'
pregnancyStringAvoid in second and third trimesters; fetal SGLT2 inhibition disrupts kidney development.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US